445 related articles for article (PubMed ID: 23265344)
1. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC;
J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.
Kowey PR; Reiffel JA; Ellenbogen KA; Naccarelli GV; Pratt CM
JAMA; 2010 Dec; 304(21):2363-72. PubMed ID: 21078810
[TBL] [Abstract][Full Text] [Related]
3. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
Bianconi L; Calò L; Mennuni M; Santini L; Morosetti P; Azzolini P; Barbato G; Biscione F; Romano P; Santini M
Europace; 2011 Feb; 13(2):174-81. PubMed ID: 21059740
[TBL] [Abstract][Full Text] [Related]
4. The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.
Macchia A; Varini S; Grancelli H; Nul D; Laffaye N; Ferrante D; Tognoni G; Doval HC;
Am Heart J; 2009 Mar; 157(3):423-7. PubMed ID: 19249410
[TBL] [Abstract][Full Text] [Related]
5. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.
Kumar S; Sutherland F; Morton JB; Lee G; Morgan J; Wong J; Eccleston DE; Voukelatos J; Garg ML; Sparks PB
Heart Rhythm; 2012 Apr; 9(4):483-91. PubMed ID: 22120130
[TBL] [Abstract][Full Text] [Related]
6. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
Mozaffarian D; Marchioli R; Macchia A; Silletta MG; Ferrazzi P; Gardner TJ; Latini R; Libby P; Lombardi F; O'Gara PT; Page RL; Tavazzi L; Tognoni G;
JAMA; 2012 Nov; 308(19):2001-11. PubMed ID: 23128104
[TBL] [Abstract][Full Text] [Related]
7. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study.
Pratt CM; Reiffel JA; Ellenbogen KA; Naccarelli GV; Kowey PR
Am Heart J; 2009 Aug; 158(2):163-169.e1-3. PubMed ID: 19619690
[TBL] [Abstract][Full Text] [Related]
9. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.
Nodari S; Triggiani M; Campia U; Manerba A; Milesi G; Cesana BM; Gheorghiade M; Dei Cas L
Circulation; 2011 Sep; 124(10):1100-6. PubMed ID: 21844082
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
Beatch GN; Mangal B
BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study.
Heidt MC; Vician M; Stracke SK; Stadlbauer T; Grebe MT; Boening A; Vogt PR; Erdogan A
Thorac Cardiovasc Surg; 2009 Aug; 57(5):276-80. PubMed ID: 19629889
[TBL] [Abstract][Full Text] [Related]
12. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
[TBL] [Abstract][Full Text] [Related]
13. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress.
Nigam A; Talajic M; Roy D; Nattel S; Lambert J; Nozza A; Jones P; Ramprasath VR; O'Hara G; Kopecky S; Brophy JM; Tardif JC;
J Am Coll Cardiol; 2014 Oct; 64(14):1441-8. PubMed ID: 25277614
[TBL] [Abstract][Full Text] [Related]
14. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
Saravanan P; Bridgewater B; West AL; O'Neill SC; Calder PC; Davidson NC
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):46-53. PubMed ID: 20042769
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
17. Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.
Ahmed S; Rienstra M; Crijns HJ; Links TP; Wiesfeld AC; Hillege HL; Bosker HA; Lok DJ; Van Veldhuisen DJ; Van Gelder IC;
JAMA; 2008 Oct; 300(15):1784-92. PubMed ID: 18854540
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.
Torp-Pedersen C; Raev DH; Dickinson G; Butterfield NN; Mangal B; Beatch GN
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):637-43. PubMed ID: 21841207
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter.
Hohnloser SH; Dorian P; Straub M; Beckmann K; Kowey P
J Am Coll Cardiol; 2004 Jul; 44(1):99-104. PubMed ID: 15234416
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion.
Komatsu T; Tachibana H; Sato Y; Ozawa M; Nakamura M; Okumura K
Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
